PROKIDNEY CORP.·4

Nov 14, 4:07 PM ET

Pereira Brian JG 4

4 · PROKIDNEY CORP. · Filed Nov 14, 2025

Insider Transaction Report

Form 4
Period: 2025-11-12
Transactions
  • Sale

    Class A Common Stock

    2025-11-13$2.37/sh447,803$1,061,2930 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2025-11-12$2.72/sh227,431$619,363447,803 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2025-11-12$2.72/sh27,595$75,15254,333 total(indirect: By Trust)
  • Sale

    Class A Common Stock

    2025-11-13$2.37/sh54,333$128,7690 total(indirect: By Trust)
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Documents

1 file
  • 4
    ownership.xmlPrimary

    4